| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 10/13/2004 | EP1465598A1 Use of oligomers and polymers for drug solublization, stabilization, and delivery |
| 10/13/2004 | EP1465597A2 Use of a lysolipid for the preparation of a composition for transfection of a polynucleotide into a cell |
| 10/13/2004 | EP1465596A1 Polymeric gel system for the controlled delivery of codrugs |
| 10/13/2004 | EP1465594A1 Solid dosage form for the ocular administration of an active principle, a soluble, solid ophthalmic insert and the production method thereof |
| 10/13/2004 | EP1465593A1 Solid orally-dispersible pharmaceutical formulation |
| 10/13/2004 | EP1465592A2 Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules |
| 10/13/2004 | EP1465591A1 Antibiotic product, use and formulation thereof |
| 10/13/2004 | EP1465590A2 Micelle compositions containing pegylated phospholipids and a photosensitizer |
| 10/13/2004 | EP1465577A2 Methods for improving the aesthetic appearance of skin |
| 10/13/2004 | EP1465563A1 METHOD OF SYSTEMICALLY DELIVERING SSRIs |
| 10/13/2004 | EP1465505A2 Stimulation of the immune system with polydextrose |
| 10/13/2004 | EP1465498A1 Center-filled chewing gum containing calcium |
| 10/13/2004 | EP1465493A1 Cultured and encapsulated pancreatic stem cells |
| 10/13/2004 | EP1381351B1 Method for the continuous production of medicaments for inhalation |
| 10/13/2004 | EP1328257A4 Biodegradable bioadhesive controlled release system of nano-particles for oral care products |
| 10/13/2004 | EP1313510B1 Injectable pharmaceutical composition for systemic delivery of pharmacologically active compounds comprising medium chain triglycerides |
| 10/13/2004 | EP1289515B1 Pharmaceutical composition containing at least a polymer associated or conjugated with at least a phenylalkylcarboxylic acid salt, conjugate polymers and uses thereof |
| 10/13/2004 | EP1267884B1 Compositions for use as penetration promoters in transdermal formulations for highly lipophilic active ingredients |
| 10/13/2004 | EP1248603B1 Use of particular compounds for prophylaxis and treatment of hepatitis c |
| 10/13/2004 | EP1207866B1 Delayed-action form of administration containing tramadol saccharinate |
| 10/13/2004 | EP1207840B1 Pharmaceutical compositions and methods for reducing the appearance of cellulite |
| 10/13/2004 | EP1206253B1 Pharmaceutical preparations containing nanosols of chitosan, and their preparation |
| 10/13/2004 | EP1200151B1 Drug delivery device for insertion into the vagina, rectum or nasal cavity |
| 10/13/2004 | EP1177217B1 Amphiphile cyclodextrins, preparation and use thereof for solubilising organised systems and incorporating hydrophobic molecules |
| 10/13/2004 | EP1154786B1 Compositions for altering mucus secretion |
| 10/13/2004 | EP1128831B1 Pharmaceutical moxifloxacin preparation |
| 10/13/2004 | EP1107802B1 Gels and multilayer surface structures from boronic acid containing polymers |
| 10/13/2004 | EP0973818B1 Biodegradable terephthalate polyester-poly(phosphate) polymers, compositions, articles, and methods for making and using the same |
| 10/13/2004 | EP0902664A4 Synchronising of animal oestrus and intra vaginal devices useful therein |
| 10/13/2004 | EP0812588B1 Pharmaceutical external preparations for topical administration comprising 2-amino-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol for the treatment of diseases induced from immune disorder |
| 10/13/2004 | EP0719147B1 Gene therapy for solid tumors, papillomas and warts |
| 10/13/2004 | EP0595838B1 Tumor rejection antigen precursors, tumor rejection antigens and uses thereof |
| 10/13/2004 | CN2647347Y Carrier suppository for gynecology use |
| 10/13/2004 | CN2647308Y Vision intensifying medical film |
| 10/13/2004 | CN1537018A Therapeutic compositions for repairing chondropathy |
| 10/13/2004 | CN1537015A Stable liquid formulations of antibodies |
| 10/13/2004 | CN1537007A 2 methyl-thieno-benzodiazepine lyophilizde formulation |
| 10/13/2004 | CN1537005A Amorphous cefditoren pivoxil composition and process for producing the same |
| 10/13/2004 | CN1537004A Compositions containing imidazotriazinone for nasal application |
| 10/13/2004 | CN1536998A Integrin inhibitors for treatment of eye diseases |
| 10/13/2004 | CN1536997A Crystalline composition containing escitalopram |
| 10/13/2004 | CN1536993A Solid pharmaceutical composition comprising 4-cyano-trifluoro-N-[3-(40fluorophenylsulphonyl)2-hydroxy-2-methylpropiono]-m-toluidide and PVP |
| 10/13/2004 | CN1536991A (f)-cycloolivil as antioxidant obtained from stereospermum personatum |
| 10/13/2004 | CN1536989A Oral compositions comprising host-respones modulating agent for promoting whole body health |
| 10/13/2004 | CN1536988A Sustained-release delivery system |
| 10/13/2004 | CN1536987A Sustained-release suspension of ceftiofur hydrochloride |
| 10/13/2004 | CN1536986A Intravaginal drug delivery devices for administration of antimicrobial agent |
| 10/13/2004 | CN1535737A Cartrige and medicine powder inhalator with integrated metering device |
| 10/13/2004 | CN1535713A Yixintong dripping pill and its preparation method |
| 10/13/2004 | CN1535710A Yuanbaofeng nervonic acid soft capsule and its preparation process |
| 10/13/2004 | CN1535709A Capsicum ethylsine tablet preparation and its preparation method |
| 10/13/2004 | CN1535708A Oral aerosol for reducing or eliminating snore and its preparation method |
| 10/13/2004 | CN1535697A Preparation of lactobacillin dispersion tablet and its preparation method |
| 10/13/2004 | CN1535694A Chinese medicine for curing tumor and its production method |
| 10/13/2004 | CN1535691A Helicid powder injection preparation and its preparation method |
| 10/13/2004 | CN1535690A Helicid soft capsule and its preparation method |
| 10/13/2004 | CN1535689A Medicine composition for curing tumor |
| 10/13/2004 | CN1535686A Slowly-released preparation containing loratadine and pseudoephedrine sulfate and its preparation method |
| 10/13/2004 | CN1535685A Adhesive plaster for curing neurodermatitis |
| 10/13/2004 | CN1535684A Aconitum kusnezoffii methylsine powder injection preparation and its preparation method |
| 10/13/2004 | CN1535683A Aconitum kusnezoffii methylsine aerosol and its preparation method |
| 10/13/2004 | CN1535680A Abidor inclusion compound |
| 10/13/2004 | CN1535678A Stable acetylglutamine freeze-dried powder injection preparation and preparation process |
| 10/13/2004 | CN1535670A Application of compound containing easily-oxidable hydrophilic active component and stabilized by maleic anhydride copolymer in face beautifying and/or dermological field |
| 10/13/2004 | CN1170622C Device for coating to be administered orally |
| 10/13/2004 | CN1170596C Composition for oral administration |
| 10/13/2004 | CN1170591C Pharmaceutical prepn. contg. fibrinolysin activators |
| 10/13/2004 | CN1170590C Health-care product containing growth factor and its preparation method |
| 10/13/2004 | CN1170586C Pharmaceutical formulation of Didemnin compound |
| 10/13/2004 | CN1170575C Exterio-applied medical wine for treating trauma |
| 10/13/2004 | CN1170570C Detoxicating ointment for treating burn and scald and its preparing process |
| 10/13/2004 | CN1170566C Externally applied pain-reliveing plaster and its prepn |
| 10/13/2004 | CN1170565C Cancer treating astringent medicine decoction |
| 10/13/2004 | CN1170563C Blood pressure stabilizing pill |
| 10/13/2004 | CN1170549C Process for preparing 'Qianjin' capsule to treat genopathy |
| 10/13/2004 | CN1170548C Pain relieving ointment and its preparation |
| 10/13/2004 | CN1170547C No-stinking fish-oil composite micro-capsule and preparation process |
| 10/13/2004 | CN1170542C Oxacarbazepine filme-coated tablets |
| 10/13/2004 | CN1170541C Oral liquid formulations of benzoxazinones HIV reverse transcriptase inhibitors |
| 10/13/2004 | CN1170540C Sustained-release theophylline tablet |
| 10/13/2004 | CN1170539C Antifungal oral composition containing itraconazole and process for preparing same |
| 10/13/2004 | CN1170534C Pharmaceutical compositions containing lipase inhibitors |
| 10/13/2004 | CN1170533C Pharmaceutically stable oxaliplatinum preparation for parenteral administration |
| 10/13/2004 | CN1170530C Patch containing 4-biphenylacetic acid |
| 10/13/2004 | CN1170527C Therapeutic perparation for inhalation containing parathyroid hormone, PTH |
| 10/13/2004 | CN1170526C A delivery system for an oral care substance using a strip of material having low flexural stiffness |
| 10/13/2004 | CN1170525C Method for producing solid dosing forms |
| 10/13/2004 | CN1170524C Fentanyl composition for treatment of acute pain |
| 10/13/2004 | CN1170523C Sustained-release drug formulations for implantation |
| 10/13/2004 | CN1170517C Water-containing powder composition and process for producing same and cosmetic preparation containing powder composition |
| 10/13/2004 | CN1170516C An inhalation anesthetic product |
| 10/12/2004 | US6803456 Used in prevention and treatment of atherosclerosis and as a dietary supplement; nutraceuticals |
| 10/12/2004 | US6803420 Hydrophobic phase and hydrophilic phase, wherein hydrophobic phase is composed of crosslinked hydrophobic polymer and hydrophilic phase is blend of hydrophilic polymer and oligomer capable of crosslinking hydrophilic polymer |
| 10/12/2004 | US6803360 Resistance to said radiation or drug treatment is not a result of overexpression of her-2, comprising introducing into said cell an antisense nucleic acid |
| 10/12/2004 | US6803061 Sustained release delivery of nutrients and/or drugs; conforms and sticks to teeth for extended masticating prior to swallowing |
| 10/12/2004 | US6803057 Hydrogen peroxide disinfectant with increased activity |
| 10/12/2004 | US6803055 Sustained release; benzazole ring structure; psychological disorders |
| 10/12/2004 | US6803054 Forming tablets from mixture of drug and sugar; dissolving in mouth |
| 10/12/2004 | US6803053 Condensed nucleic acid/lipid complex for increasing shelf life and high transfection activity in vivo following intravenous injection |
| 10/12/2004 | US6803052 Use of biodegradable microspheres that release an anticancer agent for treating gliobastoma |